Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5591762 | BOEHRINGER INGELHEIM | Benzimidazoles useful as angiotensin-11 antagonists |
Jan, 2014
(10 years ago) | |
US6358986 | BOEHRINGER INGELHEIM | Polymorphs of telmisartan |
Jan, 2020
(4 years ago) |
Market Authorisation Date: 17 November, 2000
Treatment: Treatment of hypertension
Dosage: TABLET;ORAL